When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HOTH - Hoth Therapeutics initiates preclinical study of HT-ALZ for Alzheimer's disease
Hoth Therapeutics Inc.
Hoth Therapeutics (NASDAQ:HOTH) announces that it has initiated a preclinical study of HT-ALZ for the treatment of Alzheimer's disease. The goal of the study is to determine the effects of HT-ALZ on behavioral and pathological markers of Alzheimer's disease and to determine if HT-ALZ can improve learning and memory in an animal model. Shares up nearly 2% premarket.